Breaking News:Against Jeff Sessions for Attorney General

Prescription Opiates

RSS Feed for this category

Chronicle AM: AG Nominee Stokes MJ Fears, Global Commission Calls for Drug Decrim, More... (11/21/16)

Donald Trump has nominated a harsh drug warrior to head the Justice Department, Montanans will see a slew of bills aiming at making their medical marijuana system more workable (and at least one that wants to kill it), the Global Commission on Drugs called for drug decriminalization, and more.

"Good people don't use marijuana," says Trump's attorney general pick, Alabama Sen. Jeff Sessions.
Marijuana

Trump's Pick of Jeff Sessions as AG Raises Fears in Marijuana Industry. President-elect Donald Trump (R) has nominated anti-marijuana Alabama Republican Sen. Jeff Sessions to head the Justice Department, setting off alarms in the marijuana industry. As attorney general, Sessions would oversee federal prosecutors and the DEA and could move to undo the Obama administration's policy of largely allowing the states to set their own course on pot policy.

Colorado Bureaucrats Nix On-Site Pot Consumption for Bars. Just a week after voters in Denver approved a social use initiative allowing restaurants and bars to seek permits to allow on-site consumption of marijuana, the Department of Public Health and Environment has announced that it will not allow liquor license-holders to obtain such permits. The department said using alcohol and marijuana together increases impairment. But proponents of the measure said alcohol establishments already rely on the judgment of servers and that the move would allow consumers to use marijuana products without having to go outside or hide behind closed doors.

Medical Marijuana

Arizona Dispensary Operator Eyes 2018 Expansion Initiative. The owners of the Wellness Center, an Apache Junction dispensary, are moving toward an initiative to expand the state's medical marijuana program. The move comes a week after a legalization initiative was narrowly defeated. The initiative would expand the list of qualifying conditions for marijuana and it would allow people who live more than a mile from a dispensary to grow their own. The current law bars people who live within 25 miles of a dispensary from growing their own.

After Initiative Victory, Medical Marijuana Bills Pile Up in Montana. Montanans voted last week to restore their state's medical marijuana system, which had been gutted by the Republican legislature in 2011, and now the legislature faces at least 10 bills designed either to make the system more workable or to try to thwart the will of the voters once again. It's going to be a busy session in Helena.

Heroin and Prescription Opioids

Kentucky Legislator Files Bill to Limit First-Time Opioid Prescribing. State Rep. Jeff Taylor (D-Hopkinsville) has prefiled a bill, BR 202, that would limit first-time adult prescriptions for non-chronic pain relief to a seven-day supply. The bill does include an exception that would allow a doctor to prescribe a longer supply if deemed medically necessary.

Kratom

Still Ten Days Left to Comment on Proposed Kratom Ban. Anyone who wants to commit on the DEA's plan to schedule kratom has until December 1 to do so. Click on the link for more information.

International

New Report Calls on UK to Legalize Marijuana. A new report from the Adam Smith Institute says that Great Britain's drug strategy "has failed in its core aims to prevent people from using drugs, manufacturing drugs, and to put a stop to the crime, corruption and death that is taking place on an industrial scale around the world," and calls on the government to legalize marijuana. The report is winning support from a cross-party parliamentary group that includes former deputy prime minister Nick Clegg.

Global Commission on Drugs Calls for Global Drug Decriminalization. In its annual report, the Global Commission on Drugs has called for an end to criminal and civil penalties for drug possession and more research into alternative regulatory models. The report comes months after the commission sharply criticized the United Nations' refusal to embrace more radical drug reforms at its UNGASS on Drugs last spring. Commission member Richard Branson called the UN's status quo approach "fatally flawed" at the time.

Using Medical Marijuana to Reduce Dependence on Opiates in an Aging, Aching Population [FEATURE]

Pain is a drag. And chronic pain is a never-ending drag. Unfortunately, as we grow older, we can expect to increasingly suffer its torments. Half of older adults who live on their own report suffering from chronic pain. For people in elderly care facilities, that figure jumps to somewhere around 80%.

Older patients reported relief and good quality of life with marijuana. (Darren Harris Frisby/DPA)
An aging population with its associated aches and pains is one reason opioid pain prescriptions have increased so dramatically this century. Opiates are a very popular pain management technique, despite the well-known problems with them, primarily addiction and lethality. They can ease your pain, but they can also kill you or get you strung out. And opiate users report other problems less severe, but still affecting quality of life, such as constipation and foggy-headedness.

In recent years, we have seen increasing evidence that one substance can reduce both pain and the reliance on opioids to treat it, and that its use can have a positive impact on fatal opioid overdoses. That substance is marijuana.

As the Johns Hopkins Bloomberg School of Public Health reported in 2014, "In states where it is legal to use medical marijuana to manage chronic pain and other conditions, the annual number of deaths from prescription drug overdose is 25% lower than in states where medical marijuana remains illegal."   

Now, new research findings from Care By Design, one of California's leading medical marijuana producers, add more evidence of the positive role marijuana can play in treating chronic pain and reducing dependence on opioid pain medications. The study surveyed 800 patients, mostly between 50 and 70, more than 80% of whom reported suffering from chronic pain, half of whom reported suffering from acute pain, and more than 40% of whom reported suffering from both.

These patients were in a world of hurt and had tried a number of pain management tools—opiates, medical marijuana, anti-inflammatory agents (NSAIDS), nerve blockers, exercise/physical therapy, and surgery—with respondents reporting trying an average of four of them. A quarter of patients reported having tried all six.  

The patients reported that marijuana was very effective for pain, with few negative side effects.  That was in striking distinction to opiates, which patients also said were effective for pain, but had a significant negative impact on quality of life for a significant number of them. In fact, the differences between the two substances in terms of quality of life were so dramatic they led to dramatic changes in patient behavior.

Medical marijuana (Creative Commons/Wikimedia)
"This survey brings some very important information to light," said Care By Design spokesman Nick Caston. "We see here in our patient data that cannabis is improving the quality of life of our patients—particularly elderly patients suffering from age-related pain—and that it does so without the dangerous side effects of other pain management modalities. 

"The study’s most striking finding was cannabis’ apparent impact on opiate reliance: Ninety-one percent of survey respondents reported that they decreased the amount of opiates they were taking or eliminated them altogether," Caston continued.

The study also found while marijuana, opiates, exercise/physical therapy, and NSAIDS all provided noticeable pain relief in more than half the patients, marijuana was the only pain management tool where there were no reports of worsening pain. And half of the patients using opiates reported that they had a negative impact on overall well-being, interfering with mood, energy, sleep, and functional abilities.

More than half of the patients reported using both marijuana and opiates to manage pain. But as noted above, nine out of 10 reduced or eliminated their opiate consumption after beginning to use marijuana. And nearly two-thirds (63%) said they were now off opiates altogether.

Over half of respondents reported that they had used both cannabis and opiates for pain management. Of great interest was the impact of cannabis therapy on opiate usage: Ninety-one percent of this subgroup reported that they used fewer or no opiates after beginning cannabis therapy. Sixty-three percent said that they went off opiates altogether.

"A tenet of healthcare in the United States is 'First, do no harm,'" the study concluded. "Patient reports of cannabis’ efficacy together with its low side effect profile suggest that it should be considered as a first-line treatment for pain and/or as an adjunct treatment to opiates rather than as a medication of last resort."

In other words, if we want to reduce the reliance on opioids, with all their negatives, for the management of pain in an aging population, we should be easing access to medical marijuana. With medical marijuana legal in 25 states, we're halfway there. 

Chronicle AM: Obama Says Federal Pot Prohibition "Not Tenable" After Tuesday, More... (11/07/16)

Marijuana Policy 

President Obama Says Federal Pot Prohibition in Question After Tuesday's Vote. Appearing on the Bill Maher Show Friday night, President Obama said federal marijuana prohibition will not "be tenable" if more states vote to legalize the weed on Tuesday. "The good news is is that after this referenda, to some degree it’s gonna call the question, because if in fact it passed in all these states, you now have about a fifth of the country that’s operating under one set of laws, and four-fifths in another," Obama said. "The Justice Department, DEA, FBI, for them to try to straddle and figure out how they’re supposed to enforce laws in some places and not in others — they’re gonna guard against transporting these drugs across state lines, but you’ve got the entire Pacific corridor where this is legal — that is not gonna be tenable," he said.

 

Maine Legalizers Have Huge Cash Advantage. Supporters of the Question 1 marijuana legalization initiative have raised more than $2.4 million dollars, according to campaign finance reports, while opponents have raised only $201,000. Most of the pro-legalization money has come from the New Approach PAC, the instrument of the heirs of late Progressive Insurance founder and drug reform philanthropist Peter Lewis, while 99% of the anti-legalization money has come courtesy of Project SAM's Kevin Sabet, who now heads the newly formed non-profit Alliance for Healthy Marijuana Policy.

Las Vegas Casino Magnate Sheldon Adelson Again Kicks in Against Nevada Pot Initiative. The Sands Corporation head honcho and prolific funder of anti-drug reform efforts has given more than $1.35 million to the campaign trying to defeat the Question 2 marijuana legalization initiative in recent weeks, according to campaign finance reports. That's on top of $2 million he gave opponents in September. In fact, Adelson is virtually a one-man opposition campaign, having provided 97.4% of all reported opposition campaign contributions. Proponents of Question 2 have raised only $1.2 million.

Medical Marijuana

New Report Calls Marijuana a "Promising Option" for Dealing With Opioid Addiction. A new report from the National Cannabis Industry Association finds that increasing legal access to marijuana can be a potent weapon in the fight against opioid addiction. The report findssignificant progress in reducing addiction and overdose deaths in states that have legalized it.

New Mexico Panel Votes to Allow Medical Marijuana for "Opiate Use Disorder." A state advisory board that makes recommendations to the Health Department on New Mexico’s Medical Cannabis Program voted 5-1 Friday in favor of adding "opiate use disorder" to the list of conditions that qualify. Now, it's up to incoming Health Secretary Lynn Gallagher to accept or deny the recommendation. Such a move could add thousands of new patients to the state's rapidly expanding medical marijuana program.

Asset Forfeiture

Montana Supreme Court Affirms Right to Jury Trial in Civil Forfeiture Cases. In a ruling last week, the state high court upheld and strengthened a 2015 law that reformed asset forfeiture procedures. The ruling came in the case of a man whose land was seized after police found 300 marijuana plants on it. The man was convicted of federal drug charges, but not prosecuted by the state. Even though he faced no state charges, the state seized his land. He requested a jury trial, but was denied in lower court, and a judge turned the property over to the state. But the Supreme Court said the 2015 law supplanted older law on which the trial judge based his decision.

Law Enforcement

Even As Arrests Drop, California Racial Disparities Persist. A new report from the office of Attorney General Kamala Harris finds that arrest rates for all racial groups have dropped in the past decade, but blacks were still much more likely than whites to be arrested on felony charges. When it comes to drugs, black men were six times as likely as whites to be arrested, and black women were nearly three times as likely to be arrested as whites. Latinos, on the other hand, were arrested for drugs at roughly the same rate as whites. 

Clinton's and Trump's Drug Policies [FEATURE]

(This article was written prior to the election.)

One means of judging the competing presidential candidates is to examine their actual policy prescriptions for dealing with serious issues facing the country. When it comes to drug policy, the contrasts between Hillary Clinton and Donald Trump couldn't be more telling.

Donald Trump talks drugs. (Gage Skidmore/Wikimedia)
The country is in the midst of what can fairly be called an opioid crisis, with the CDC reporting 78 Americans dying every day from heroin and prescription opioid overdoses. Both candidates have addressed the problem on the campaign trail, but, as is the case in so many other policy areas, one candidate has detailed proposals, while the other offers demagogic sloganeering.

Guess which is which.

Hillary Clinton has offered a detailed $10 billion plan to deal with what she called the "quiet epidemic" of opioid addiction. Donald Trump's plan consists largely of "build the wall."

That was the centerpiece of his October 15 speech in New Hampshire where he offered his clearest drug policy prescriptions yet (though it was overshadowed by his weird demand that Hillary Clinton undergo a drug test).  To be fair, since then, Trump has also called for expanding law enforcement and treatment programs, but he has offered no specifics or cost estimates.

And the centerpiece of his approach remains interdiction, which dovetails nicely with his nativist immigration positions.

Donald Trump wants a wall here to stop drugs and immigrants. (Wikimedia/Creative Commons)
"A Trump administration will secure and defend our borders," he said in that speech. "A wall will not only keep out dangerous cartels and criminals, but it will also keep out the drugs and heroin poisoning our youth."

Trump did not address the failure of 40 years of ever-increasing border security and interdiction policies to stop the flow of drugs up until now, nor did he explain what would prevent a 50-foot wall from being met with a 51-foot ladder.

Trump's drug policy also takes aim at a favorite target of conservatives: so-called sanctuary cities, where local officials refuse to cooperate in harsh federal deportation policies.

"We are also going to put an end to sanctuary cities, which refuse to turn over illegal immigrant drug traffickers for deportation," he said. "We will dismantle the illegal immigrant cartels and violent gangs, and we will send them swiftly out of our country."

In contrast, Clinton's detailed proposal calls for increased federal spending for prevention, treatment and recovery, first responders, prescribers, and criminal justice reform. The Clinton plan would send $7.5 billion to the states over 10 years, matching every dollar they spend on such programs with four federal dollars. Another $2.5 billion would be designated for the federal Substance Abuse Prevention and Treatment Block Grant program.

Hillary Clinton has a detailed drug policy position. (state.gov)
While Trump advocates increased border and law enforcement, including a return to now widely discredited mandatory minimum sentencing for drug offenders, Clinton does not include funding for drug enforcement and interdiction efforts in her proposal. Such funding would presumably come through normal appropriations channels.

Instead of a criminal justice crackdown, Clinton vows that her attorney general will issue guidance to the states urging them to emphasize treatment over incarceration for low-level drug offenders. She also supports alternatives to incarceration such as drug courts (as does Trump). But unlike Trump, Clinton makes no call for increased penalties for drug offenders.

Trump provides lip service to prevention, treatment and recovery, but his rhetorical emphasis illuminates his drug policy priorities: more walls, more law enforcement, more drug war prisoners.

There is one area of drug policy where both candidates are largely in agreement, and that is marijuana policy. Both Clinton and Trump have embraced medical marijuana, both say they are inclined to let the states experiment with legalization, but neither has called for marijuana legalization or the repeal of federal pot prohibition.

If Clinton's drug policies can be said to be a continuation of Obama's, Trump's drug policies are more similar to a return to Nixon's. 

(This article was prepared by StoptheDrugWar.org"s lobbying arm, the Drug Reform Coordination Network, which also pays the cost of maintaining this web site. DRCNet Foundation takes no positions on candidates for public office, in compliance with section 501(c)(3) of the Internal Revenue Code, and does not pay for reporting that could be interpreted or misinterpreted as doing so.)

Flailing Trump Pivots to Drug Policy, Demands Hillary Drug Test, Pivots Away Again [FEATURE]

This article was produced in collaboration with AlterNet and first appeared here.

Reeling from allegation after allegation of sexual misconduct, Republican presidential contender Donald Trump tried to go on the offensive on drug policy over the weekend, but in a manner typical of his campaign, he touched only briefly on the topic before flying off on new tangents, and he began his drug policy interlude with a bizarre attack on Hillary Clinton.

Donald Trump talks drugs. (Gage Skidmore/Wikimedia)
At a speech at a Toyota dealership in Portsmouth, New Hampshire, Saturday, the GOP candidate claimed that Clinton was on performance-enhancing drugs before their last debate and suggested drug tests were in order.

"Why don't we do that?" he demanded, adding that Clinton was likely "getting pumped up" as the prepared for that debate.

"We should take a drug test prior cause I don't know what's going on with her. But at the beginning of last debate, she was all pumped up at the beginning and at the end it was like, oh take me down. She could barely reach her car," he claimed.

The claim didn't come out of nowhere. Trump was echoing an ad from two weeks ago from the pro-Trump super PAC Make America Number 1 that showed Clinton coughing and then stumbling to her van on the morning of September 11. The super PAC is bankrolled by Trump backer and big time conservative donor Robert Mercer, who dropped $2 million on the PAC in July.

The unfounded allegation of Clinton pre-debate drug use and the demand for a drug test grabbed media attention, but if Trump was attempting to turn a corner and shift the campaign's focus away from his peccadillos, his strange accusation against Clinton only served to raise more questions about his temperament and suitability for the nation's highest office.

Trump wanted Hillary Clinton to submit to a pre-debate drug test. (Wikimedia)
And it virtually smothered any discussion of actual drug policy proposals Trump made during the speech. While Trump has obliquely addressed the heroin and prescription opioid problem in the past, Saturday's speech was the first time he tried to put any flesh on his proposals for dealing with it.

If anyone were paying attention to the policy details amidst all the racket about the drug test challenge, they would have heard drug policy proposals rooted squarely in the failed drug war strategies of the last century.

Trump would, he said, block drugs from coming into the US by -- you guessed it -- building the wall on the Mexican border. He would also seek to tighten restrictions on the prescribing of opioids. And he would reinstitute mandatory minimum sentences for drug offenders.

"We have 5 percent of the world's population but use 80 percent of the prescription opioids," Trump said, eerily echoing former rival Jeb Bush, who used the same language while campaigning in the state earlier this year.

That statistic is aimed at showing that the US is over-prescribing narcotic pain killers, but according to the World Health Organization, the actuality is that in much of the rest of the world, they are underprescribing them. In fact, the WHO said that in more than 150 countries with 83 percent of the global population, there is virtually no access to prescription opioids for relief of pain.

And the under-treatment of chronic pain isn't just a problem in India or China or Africa. According to the National Institute of Health, more than 50 million Americans suffer significant chronic or severe pain. An opioid policy that focuses only on reducing prescriptions without addressing the need for access to pain killing opioids for actual pain is only half a policy.

When it comes to the border, Trump correctly asserts that Mexico is the source of most of the heroin in the US (it produces 45% itself and another 51% comes from Latin America, mostly Colombia and Guatemala, often through Mexico), but relies on a hyper-interdiction policy ("build the wall") to thwart it. Interdiction -- blocking the flow of drugs into the country -- has been a pillar of US drug policy for decades, but despite massive border build ups and the doubling of the number of Customs and Border Patrol agents in the past 15 years, the drugs still flow.

Long after their popularity wanes, Trump calls for new mandatory minimum sentences for drug offenders. (nadcp.org)
Interdiction hasn't done the trick so far, and there is no indication that even a Trumpian wall would make a difference. The creativity of drug smugglers is legendary, and the economic incentives under drug prohibition are great. As the saying goes, "Build a 50-foot wall, and they'll bring a 51-foot ladder" (or a tunnel).

The third component of his drug policy is a Reaganesque "lock 'em up." In his New Hampshire speech, he saluted running mate Mike Pence for increasing mandatory minimums for drug offenders as governor of Indiana.

"We must make similar efforts a priority for the nation," Trump said.

That position flies in the face of a growing bipartisan consensus that the use of mandatory minimums for drug offenses is draconian, ineffective, and harms mainly minority populations. During the Obama administration, mandatory minimum sentences have been reduced with congressional assent, and Obama himself has granted commutations to hundreds of drug war prisoners serving those draconian sentences, with little dissent.

Trump's drug policy is but a sketch, but even its vague outlines reflect outdated approaches to the issue and a quickness to resort to cheap demagoguery on the issue. Still, while there is plenty of room for discussion of his approach, Trump has apparently already left the issue behind, barely mentioning it since Saturday as he tilts at other windmills.

(This article was prepared by StoptheDrugWar.org's lobbying arm, the Drug Reform Coordination Network, which also pays the cost of maintaining this web site. DRCNet Foundation takes no positions on candidates for public office, in compliance with section 501(c)(3) of the Internal Revenue Code, and does not pay for reporting that could be interpreted or misinterpreted as doing so.)

Chronicle AM: Prohibitionists Give Big Bucks to Defeat Pot Inits, Trump on Drugs, More... (10/17/16)

Million dollar donations flow to the "no" forces in Arizona and Massachusetts, the Arizona initiative is in a dead heat according to a new poll, Donald Trump talks drugs and demands Hillary take a drug test, and more.

Las Vegas casino magnate Sheldon Adelson bankrolls anti-marijuana reform efforts. (Creative Commons)
Marijuana Policy

New Arizona Poll Has Legalization in Dead Heat. A poll from Data Orbital released Friday has the Prop 205 legalization initiative in a statistical tie. The poll had support at 45%, with 44% opposed, 5% undecided, and, apparently, 6% unaccounted for. Pollster and political consultant George Khalaf said the "no" side was making gains because of heavy TV advertising in recent weeks. "It's not that good for a proposition to be this far below 50%," he said of the "yes" side. "It's not a great sign for legalization, unless they outspend (the 'no' side) in next few weeks or younger voters' turnout is larger than anticipated."

Discount Tire Kicks in $1 Million to Defeat Arizona Legalization. The Scottsdale-based Discount Tire Company has contributed a million dollars to Arizonans for Responsible Drug Policy, the group leading the "no" campaign against Prop 205. The company is the largest privately held company in the state, and has also contributed to controversial Sheriff Joe Arpaio. The "no" campaign has also seen recent large donations from Empire Southwest for $200,000 and SAM (Smart About Marijuana) Action for $115,000.

Delaware Poll Has Solid Majority for Legalization. A new poll from the University of Delaware's Center for Political Communication has support for marijuana legalization at 61%. Only 35% of respondents said they were opposed. The poll comes as state Sen. Margaret Rose Henry (D-Wilmington) says she plans to introduce a legalization bill when the legislature reconvenes.

Sheldon Adelson Kicks in $1 Million to Defeat Massachusetts Legalization. Las Vegas casino magnate and ultra-conservative philanthropist Sheldon Adelson had donated $1 million to the Campaign for a Safe and Healthy Massachusetts, which is leading the opposition to the Question 4 legalization initiative. Even with the Adelson money, however, the "yes" side has out fundraised the "no" side by a margin of two-to-one. Yes on 4 has raised more than $3.3 million, while the opposition has raised only $1.6 million.

Drug Policy

Trump Talks Drug Policy, Demands Hillary Take Drug Test. Donald Trump sketched out a policy aimed at the heroin and opioid crisis during a speech in New Hampshire Saturday, but it was largely drowned out by his call for Hillary Clinton to undergo a drug test before their next debate. Trump said he suspected she was on something during the last debate. When it came to heroin and opioids, Trump said he would solve the problem by building a wall on the Mexican border, moving to reduce the prescribing of opioid pain medications, and resorting to mandatory minimum sentences for drug offenders.

International

Scottish National Party Backs Medical Marijuana.Meeting at its annual national conference, the Scottish National Party backed the medicinal use of marijuana. The vote doesn't necessarily mean the Scottish government will adopt medical marijuana, and drug policy is an area specifically reserved to the UK national parliament, so that body would have to act as well.

(This article was prepared by StoptheDrugWar.org's lobbying arm, the Drug Reform Coordination Network, which also pays the cost of maintaining this web site. DRCNet Foundation takes no positions on candidates for public office, in compliance with section 501(c)(3) of the Internal Revenue Code, and does not pay for reporting that could be interpreted or misinterpreted as doing so.)

Chronicle AM: DEA Cuts Prescription Opioid Production Quotas, Legal Pot Sales Keep Getting Higher, More... (10/4/16)

The campaign ads start rolling out in Maine and Massachusetts, legal pot sales keep getting higher, the DEA cuts quotas for prescription opioid manufacturing, and more.

The maker of Suboxone is accused of price gouging and patent manipulation. (Wikimedia.org)
Marijuana Policy

Legal Pot Sales Keep Going Up, Up, Up. This year is on track to be another record-setter when it comes to legal marijuana sales. A new report from the financial services company Convergex finds that sales growth at legal pot shops in Colorado, Oregon, and Washington was "impressive." Through July, Colorado has already done $458.7 million in revenues, while Washington has come in at $415.8 million through August. The Colorado figure is only 20% below the total for all of 2015, while the Washington figure already exceeds sales for all of last year. Oregon dispensaries reported $42.4 million in retail sales in June and July.

New England Legalization Initiatives Launch First TV Ads. The Question 1 campaign in Maine and the Question 4 campaign in Massachusetts both rolled out their first television ads Monday. The Massachusetts ads feature a former Boston police officer who is now a criminal justice professor, while the Maine ad also features a former law enforcement official, former Cumberland County Sheriff Mark Dion.

Heroin and Prescription Opioids

DEA Reduces Amount of Opioid Controlled Substances. The DEA announced Tuesday that it is reducing quotas for the amount of Schedule II opiates and opioid medications that can be produced in the US next year by 25% or more. DEA said it is responding to decreased demand for these substances, based on reduced prescribing of them. The quota has been cut by 25% for oxycodone, hydrocodone, fentanyl, hydromorphone, morphine, and other such medications and a whopping 66% for hydrocodone.

Thirty-Five States and DC Sue Suboxone Maker Over Price Gouging. Illinois is among the 35 states and the District of Columbia that have filed a lawsuit against the drugmaker Indivior over its maneuvers to keep a monopoly on the market for Suboxone, which is used to treat patients addicted to heroin and other opioids. The lawsuit charges that Indivior changed Suboxone from a tablet to a dissolving film only in order to get a new patent that would protect it from competition and allow it to charge exorbitant prices. The company has made over a billion dollars in annual sales every year since 2009, when the original patent was set to expire. "These companies rigged a system to ensure they profited at the expense of the people who depended on this drug to treat and recover from addiction," Illinois Attorney General Lisa Madigan said in a statement.

Chronicle AM: Chelsea Clinton "Misspoke" on MJ Dangers, NYC Safe Injection Sites?, More... (9/29/16)

No, medical marijuana doesn't kill patients, Chelsea Clinton's spokeswoman admits, New York City is about to embark on a study of supervised injection facilities, and more.

The InSite supervised injection facility in Vancouver. New York City will study whether to have them, too. (vch.ca)
Medical Marijuana

Chelsea Clinton "Misspoke" About Risk of Marijuana Fatalities. Chelsea Clinton "misspoke" when she suggested that using medical marijuana along with other medications could be fatal, a spokeswoman has conceded. "While discussing her and her mother's support for rescheduling marijuana to allow for further study of both its medical benefits and possible interactions with other medications, Chelsea misspoke about marijuana's interaction with other drugs contributing to specific deaths," the spokeswoman said. While campaigning for her mother, the former first daughter told students at Youngstown State University in Ohio over the weekend that "some of the people who were taking marijuana for those [medicinal] purposes, the coroner believes, after they died, there was drug interactions with other things they were taking."

Harm Reduction

New York City to Study Supervised Injection Facilities. The city council has agreed to fund a $100,000 study into the pros and cons of supervised injection facilities. "The Council's new supervised injection impact study will assess the feasibility and impact of New York City having a program that provides a safe, clean haven to high-risk, vulnerable New Yorkers and will help prevent drug overdoses and disease transmissions, "Council Speaker Melissa Mark-Viverito said after passage of the proposal.

Law Enforcement

GOP Congressman's Bill Would Subject Heroin Spiked with Fentanyl Dealers to the Death Penalty. Rep. Tom Reed (R-NY) has filed a bill that would allow federal prosecutors to seek the death penalty for dealers linked to an overdose death caused by heroin laced with fentanyl. The measure is HR 6158, the Help Ensure Lives are Protected (HELP) Act. The move was quickly criticized by drug reform advocates. "This bill is a doubling down on the very ineffective, harsh and punitive policies that characterized the early war on drugs and which have widely been proven ineffective at reducing drug use," said Lindsay LaSalle, senior staff attorney for the Drug Policy Alliance.

(This article was prepared by StoptheDrugWar.org's lobbying arm, the Drug Reform Coordination Network, which also pays the cost of maintaining this web site. DRCNet Foundation takes no positions on candidates for public office, in compliance with section 501(c)(3) of the Internal Revenue Code, and does not pay for reporting that could be interpreted or misinterpreted as doing so.)

Chronicle AM: CA "Doctor Shopping" Law, Strong FL MedMJ Polling, Iran Executions More... (9/28/16)

The polls are looking good in Florida and Massachusetts, California's governor signs a mandatory prescription monitoring bill, Iran executes more drug offenders, and more.

Marijuana Policy

California Nurses Endorse Legalization Initiative. The California Nurses Association has formally endorsed the Prop 64 legalization initiative. "California Nurses believe strongly that the prohibition and criminalization of marijuana has ruined generations of lives, wasted hundreds of millions of taxpayer of dollars and failed to protect the public health and safety, "Deborah Burger, the organization's president said in a prepared statement Tuesday. "On balance, Proposition 64 is significantly better for public health and safety than the broken status quo, and we are pleased to endorse it,"she added. The California Medical Association has also endorsed Prop 64; the California Hospitals Association opposes it.

Massachusetts Legalization Initiative Favored in New Poll. A new WBZ-TV/UMass Amherst poll has the Question 4 legalization initiative favored by 53% of respondents, with 40% opposed and 7% undecided. Of demographic groups, only voters over 55 and self-described conservatives opposed the measure.

Medical Marijuana

Florida Medical Marijuana Initiative Cruising to Victory in New Poll. A Florida Chamber of Commerce poll has 73% of voters favoring the Amendment 2 medical marijuana initiative, with only 22% opposed. Because it is a constitutional amendment, the initiative needs 60% to pass, but it is polling well beyond that.

Heroin and Prescription Opioids

California Governor Signs Prescription Monitoring Bill into Law. Gov. Jerry Brown (D) Tuesday signed into law Senate Bill 482, aimed at preventing "doctor shopping." The new law requires doctors to check a database of prescription drug prescriptions before writing prescriptions for potentially addictive drugs. The state already has an electronic prescription database, but until now it's use has been optional. The new law will go into effect in six months.

International

Iran Hangs Five More Drug Offenders. Iranian authorities executed four drug prisoners at Tabriz Central Prison on Saturday and one more at Taybad Prison on Sunday. Their names were Abdolkarim Bapiri, Mehdi Molaie, Salah Ghaderian, Ali Mohtabipour, and Hadi Oskouie. In recent years, Iran has executed hundreds of drug offenders each year.

Chronicle AM: OR Top Cops Want Defelonization, SC County Wants to Jail Overdosers, More... (9/27/16)

NORML updates its congressional scorecard, Bay State legalizers cry foul over a misleading voter guide, the number of babies suffering from opioid withdrawals has jumped dramatically, Oregon top cops want to defelonize simple drug possession, and more.

Oregon sheriffs and police chiefs jointly call for defelonizing simple drug possession. (Creative Commons)
Marijuana Policy

NORML Releases Updated and Revised 2016 Congressional Scorecard. To mark national Voter Registration Day, NORML has released its updated and revised guide to members of Congress. The guide gives letter grades to our representatives based on the comments and voting records. Only 22 of the 535 senators and congressmen got "A" grades, while 32 members got an "F" grade.

Massachusetts Legalizers Cry Foul Over State-Issued Voter Guide. Campaigners behind the Question 4 legalization initiative say a state-issued guide sent to voters across the state inaccurately describes the fiscal consequences of the measure. The guide says they are "difficult to project due to lack of reliable data" and cites a report from a committee headed by a top opponent of legalization to the effect that taxes and fee revenues from legal marijuana sales "may fall short of even covering the full public and social costs. The Yes on 4 campaign points out that there is "reliable data" from legal marijuana states and that those states have easily covered administrative and other expenses.

Heroin and Prescription Opioids

Study: Number of Babies Born Suffering Withdrawal Symptoms More Than Doubles in Four Years. Researchers studying neonatal abstinence syndrome, which results from withdrawal from opioids to which fetuses were exposed in utero, report that the incidence of the syndrome has jumped from 2.8 cases per thousand live births in 2009 to 7.3 cases in 2013. At least some of the surge may be a result of drug policies aimed at cracking down on prescription drug use. "The drug policies of the early 2000s were effective in reducing supply -- we have seen a decrease in methamphetamine abuse and there have been reductions in some aspects of prescription drug abuse," said lead study author Dr. Joshua Brown. "However, the indirect results, mainly the increase in heroin abuse, were likely not anticipated and we are just starting to see these." The researchers also noted wide variations by state, from 0.7 cases per thousand in Hawaii to 33.4 cases in West Virginia.

New Psychoactive Substances

Bill to Criminalize More New Synthetics Passes House. A bill sponsored by Rep. Charlie Dent (R-TX) to add several new synthetic cannabinoids and opioids to the Controlled Substances Act passed the House Monday. The measure, HR 3537, now goes to the Senate.

Law Enforcement

Oregon Law Enforcement Calls for Defelonizing Drug Possession. The Oregon Association of Police Chiefs and the Oregon State Sheriff's Association have jointly called for people caught with "user amounts" of illegal drugs to face misdemeanor charges -- not felonies -- and be sent to treatment. Elected officials and prosecutors should "craft a more thoughtful approach to drug possession when it is the only crime committed," the top cops said, because felony charges "include unintended and collateral consequences including barriers to housing and employment and a disparate impact on minority communities."

South Carolina County Ponders Mandatory Jail Time for People Who Overdose. The chairman of the county council in Horry County, where Myrtle Beach is located, has inquired during a council meeting about whether to make people who suffer opioid overdoses spend three days in jail. Chairman Mark Lazarus would also like to see mandatory drug treatment required. He added that jailing people who overdose wouldn't discourage them from getting medical help because they're usually unconscious and someone else calls for emergency assistance.

Drug War Issues

Criminal JusticeAsset Forfeiture, Collateral Sanctions (College Aid, Drug Taxes, Housing, Welfare), Court Rulings, Drug Courts, Due Process, Felony Disenfranchisement, Incarceration, Policing (2011 Drug War Killings, 2012 Drug War Killings, 2013 Drug War Killings, 2014 Drug War Killings, 2015 Drug War Killings, 2016 Drug War Killings, Arrests, Eradication, Informants, Interdiction, Lowest Priority Policies, Police Corruption, Police Raids, Profiling, Search and Seizure, SWAT/Paramilitarization, Task Forces, Undercover Work), Probation or Parole, Prosecution, Reentry/Rehabilitation, Sentencing (Alternatives to Incarceration, Clemency and Pardon, Crack/Powder Cocaine Disparity, Death Penalty, Decriminalization, Defelonization, Drug Free Zones, Mandatory Minimums, Rockefeller Drug Laws, Sentencing Guidelines)CultureArt, Celebrities, Counter-Culture, Music, Poetry/Literature, Television, TheaterDrug UseParaphernalia, ViolenceIntersecting IssuesCollateral Sanctions (College Aid, Drug Taxes, Housing, Welfare), Violence, Border, Budgets/Taxes/Economics, Business, Civil Rights, Driving, Economics, Education (College Aid), Employment, Environment, Families, Free Speech, Gun Policy, Human Rights, Immigration, Militarization, Money Laundering, Pregnancy, Privacy (Search and Seizure, Drug Testing), Race, Religion, Science, Sports, Women's IssuesMarijuana PolicyGateway Theory, Hemp, Marijuana -- Personal Use, Marijuana Industry, Medical MarijuanaMedicineMedical Marijuana, Science of Drugs, Under-treatment of PainPublic HealthAddiction, Addiction Treatment (Science of Drugs), Drug Education, Drug Prevention, Drug-Related AIDS/HIV or Hepatitis C, Harm Reduction (Methadone & Other Opiate Maintenance, Needle Exchange, Overdose Prevention, Safe Injection Sites)Source and Transit CountriesAndean Drug War, Coca, Hashish, Mexican Drug War, Opium ProductionSpecific DrugsAlcohol, Ayahuasca, Cocaine (Crack Cocaine), Ecstasy, Heroin, Ibogaine, ketamine, Khat, Kratom, Marijuana (Gateway Theory, Marijuana -- Personal Use, Medical Marijuana, Hashish), Methamphetamine, New Synthetic Drugs (Synthetic Cannabinoids, Synthetic Stimulants), Nicotine, Prescription Opiates (Fentanyl, Oxycontin), Psychedelics (LSD, Mescaline, Peyote, Salvia Divinorum)YouthGrade School, Post-Secondary School, Raves, Secondary School